4.8 Article

ATMIN Is Required for Maintenance of Genomic Stability and Suppression of B Cell Lymphoma

期刊

CANCER CELL
卷 19, 期 5, 页码 587-600

出版社

CELL PRESS
DOI: 10.1016/j.ccr.2011.03.022

关键词

-

资金

  1. Experimental HistoPathology Unit, Bioinformatics and Biostatistics
  2. Equipment Park, Biological Resources
  3. FAGS Lab in the London Research Institute (CRUK)
  4. Marie-Curie Intra-European Fellowship [MEIF-CT-2006-041119]
  5. Wellcome Trust
  6. Cancer Research UK
  7. Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C163, BB/F012217/1] Funding Source: researchfish
  8. Medical Research Council [MC_U105178806] Funding Source: researchfish
  9. BBSRC [BB/F012217/1] Funding Source: UKRI
  10. MRC [MC_U105178806] Funding Source: UKRI

向作者/读者索取更多资源

Defective V(D)J rearrangement of immunoglobulin heavy or light chain (IgH or IgL) or class switch recombination (CSR) can initiate chromosomal translocations. The DNA-damage kinase ATM is required for the suppression of chromosomal translocations but ATM regulation is incompletely understood. Here, we show that mice lacking the ATM cofactor ATMIN in B cells (ATMIN(Delta B/Delta B)) have impaired ATM signaling and develop B cell lymphomas. Notably, ATMIN(Delta B/Delta B) cells exhibited defective peripheral V(D)J rearrangement and CSR, resulting in translocations involving the Igh and Igl loci, indicating that ATMIN is required for efficient repair of DNA breaks generated during somatic recombination. Thus, our results identify a role for ATM IN in regulating the maintenance of genomic stability and tumor suppression in B cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

Antigen retrieval and clearing for whole-organ immunofluorescence by FLASH

Hendrik A. Messal, Jorge Almagro, May Zaw Thin, Antonio Tedeschi, Alessandro Ciccarelli, Laura Blackie, Kurt I. Anderson, Irene Miguel-Aliaga, Jacco van Rheenen, Axel Behrens

Summary: The FLASH technique is a quick and customizable method for molecular phenotyping of intact tissue volumes. It enables detection of a multitude of antigens in whole mouse organs and embryos, human biopsies, organoids, and Drosophila. FLASH allows for epithelial marker retrieval and immunolabeling, and preserves sample architecture for subsequent histopathological analysis.

NATURE PROTOCOLS (2021)

Article Oncology

High-throughput drug screening identifies the ATR-CHK1 pathway as a therapeutic vulnerability of CALR mutated hematopoietic cells

Ruochen Jia, Leon Kutzner, Anna Koren, Kathrin Runggatscher, Peter Majek, Andre C. Mueller, Michael Schuster, Christoph Bock, Joanna I. Loizou, Stefan Kubicek, Robert Kralovics

Summary: Mutations of calreticulin (CALR) are the second most common driver mutations in essential thrombocythemia and primary myelofibrosis. A study identified synthetic lethality with compounds targeting the ATR-CHK1 pathway in CALR mutated cells, highlighting the potential therapeutic target in CALR mutated hematopoietic cells. CHK1 inhibitors induced replication stress and S-phase cell cycle arrest in CALR mutated cells, demonstrating specificity for the oncogenic activation by the mutant CALR.

BLOOD CANCER JOURNAL (2021)

Article Medicine, Research & Experimental

Deficient adaptation to centrosome duplication defects in neural progenitors causes microcephaly and subcortical heterotopias

Jose Gonzalez-Martinez, Andrzej W. Cwetsch, Diego Martinez-Alonso, Luis R. Lopez-Sainz, Jorge Almagro, Anna Melati, Jesus Gomez, Manuel Perez-Martinez, Diego Megias, Jasminka Boskovic, Javier Gilabert-Juan, Osvaldo Grana-Castro, Alessandra Pierani, Axel Behrens, Sagrario Ortega, Marcos Malumbres

Summary: The study reveals that defects in certain genes during development can lead to mild MCPH symptoms, while the lack of centrosome or centriole regulators can cause chromosomal instability in neural progenitor cells.

JCI INSIGHT (2021)

Article Medicine, Research & Experimental

JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer

E. Josue Ruiz, Linxiang Lan, Markus Elmar Diefenbacher, Eva Madi Riising, Clive Da Costa, Atanu Chakraborty, Joerg D. Hoeck, Bradley Spencer-Dene, Gavin Kelly, Jean-Pierre David, Emma Nye, Julian Downward, Axel Behrens

Summary: In a mouse model of K-RasG12D-induced lung adenocarcinoma, deletion or mutation of c-Jun unexpectedly increased lung tumor burden, while the Jun family member JunD was found to be crucial in JNK signaling and Ras-induced lung cancer in the absence of c-Jun.

JCI INSIGHT (2021)

Article Cell Biology

PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway

Huafu Li, Chunming Wang, Linxiang Lan, Wenhui Wu, Ian Evans, E. Josue Ruiz, Leping Yan, Zhijun Zhou, Joaquim M. Oliveira, Rui L. Reis, Zhenran Hu, Wei Chen, Axel Behrens, Yulong He, Changhua Zhang

Summary: The study identified PARP1 gene as a key mediator of OXA resistance and proposed a combination therapy strategy using OXA and Olaparib to target this resistance mechanism. The results showed significant correlation between PARP1 expression and OXA resistance, with genetic manipulation confirming its role in mediating resistance. The combination therapy effectively inhibited the growth and viability of OXA-resistant organoids both in vivo and in vitro.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

METTL3 promotes oxaliplatin resistance of gastric cancer CD133+stem cells by promoting PARP1 mRNA stability

Huafu Li, Chunming Wang, Linxiang Lan, Leping Yan, Wuguo Li, Ian Evans, E. Josue Ruiz, Qiao Su, Guangying Zhao, Wenhui Wu, Haiyong Zhang, Zhijun Zhou, Zhenran Hu, Wei Chen, Joaquim M. Oliveira, Axel Behrens, Rui L. Reis, Changhua Zhang

Summary: In this study, the researchers investigated the mechanism of oxaliplatin resistance in gastric cancer using in vitro human gastric cancer organoids and oxaliplatin-resistant cell lines, as well as in vivo tumorigenicity experiments. They found that CD133+ stem cell-like cells are the main subpopulation associated with resistance, and that the gene PARP1 plays a central role in mediating this resistance. The researchers discovered that PARP1 can effectively repair DNA damage caused by oxaliplatin by activating the base excision repair pathway, leading to the development of drug resistance. They also found that CD133+ cells exhibit increased expression of the mRNA modification N6-methyladenosine (m6A) and its writer METTL3, which enhances the stability of PARP1 and contributes to its DNA damage repair ability. Overall, this study demonstrates that m6A methyltransferase METTL3 promotes oxaliplatin resistance in CD133+ gastric cancer stem cells by increasing PARP1 mRNA stability and base excision repair activity.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Biochemistry & Molecular Biology

The Jun-dependent axon regeneration gene program: Jun promotes regeneration over plasticity

Matthew R. J. Mason, Susan van Erp, Kim Wolzak, Axel Behrens, Gennadij Raivich, Joost Verhaagen

Summary: The regeneration-associated gene expression program is crucial for axon re-growth in injured peripheral neurons. Jun, a transcription factor, plays an important role in regulating this program by upregulating gene expression and promoting cell regeneration while inhibiting plasticity response.

HUMAN MOLECULAR GENETICS (2022)

Article Biology

USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma

E. Josue Ruiz, Adan Pinto-Fernandez, Andrew P. Turnbull, Linxiang Lan, Thomas M. Charlton, Hannah C. Scott, Andreas Damianou, George Vere, Eva M. Riising, Clive Da Costa, Wojciech W. Krajewski, David Guerin, Jeffrey D. Kearns, Stephanos Ioannidis, Marie Katz, Crystal McKinnon, Jonathan O'Connell, Natalia Moncaut, Ian Rosewell, Emma Nye, Neil Jones, Claire Heride, Malte Gersch, Min Wu, Christopher J. Dinsmore, Tim R. Hammonds, Sunkyu Kim, David Komander, Sylvie Urbe, Michael J. Clague, Benedikt M. Kessler, Axel Behrens

Summary: Lung squamous cell carcinoma (LSCC) is a significant global health burden with limited treatment options, but inhibition of USP28 can lead to tumor regression.
Article Multidisciplinary Sciences

USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer

Jessica K. Nelson, May Zaw Thin, Theodore Evan, Steven Howell, Mary Wu, Bruna Almeida, Nathalie Legrave, Duco S. Koenis, Gabriela Koifman, Yoichiro Sugimoto, Miriam Llorian Sopena, James MacRae, Emma Nye, Michael Howell, Ambrosius P. Snijders, Andreas Prachalias, Yoh Zen, Debashis Sarker, Axel Behrens

Summary: This study reveals that the deubiquitinating enzyme USP25 promotes growth and survival of pancreatic ductal adenocarcinoma (PDAC) by stabilizing and regulating the transcriptional activity of HIF-1 protein. PDAC is characterized by a severely hypoxic microenvironment, and inhibition of USP25 impairs HIF-1 activity and induces cell death in the tumor core. The USP25/HIF-1α axis may be a potential therapeutic target for PDAC.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

GREM1 is required to maintain cellular heterogeneity in pancreatic cancer

Linxiang Lan, Theodore Evan, Huafu Li, Aasia Hussain, E. Josue Ruiz, May Zaw Thin, Rute M. M. Ferreira, Hari Ps, Eva M. Riising, Yoh Zen, Jorge Almagro, Kevin W. Ng, Pablo Soro-Barrio, Jessica Nelson, Gabriela Koifman, Joana Carvalho, Emma L. Nye, Yulong He, Changhua Zhang, Anguraj Sadanandam, Axel Behrens

Summary: This study identifies BMP inhibitor GREM1 as a key regulator of cellular heterogeneity in pancreatic cancer. Continuous activity of GREM1 is required to maintain the stability of the epithelial PDAC subpopulations, while high activity of GREM1 can revert the mesenchymal fate of PDAC cells. By inhibiting the expression of epithelial-mesenchymal transition transcription factors, GREM1 restricts the epithelial-mesenchymal plasticity of pancreatic cancer cells.

NATURE (2022)

Article Multidisciplinary Sciences

USP7 controls NGN3 stability and pancreatic endocrine lineage development

Teodora Manea, Jessica Kristine Nelson, Cristina Maria Garrone, Karin Hansson, Ian Evans, Axel Behrens, Rocio Sancho

Summary: Understanding the role of NGN3 in beta-cell development is crucial for developing therapies for diabetes. This study identifies USP7 as a key regulator of NGN3 stability and shows that it is necessary for endocrine development and beta-cell differentiation. Inhibition of USP7 reduces NGN3 expressing progenitor cell numbers and impairs beta-cell differentiation. The findings suggest that targeting the USP7-NGN3 axis could be a therapeutic strategy for generating functional beta cells.

NATURE COMMUNICATIONS (2023)

Article Biochemical Research Methods

Differentiation of beta-like cells from human induced pluripotent stem cell-derived pancreatic progenitor organoids

Sergio Pedraza-Arevalo, Ana-Maria Cujba, Mario Enrique Alvarez-Fallas, Rocio Sancho

Summary: This study presents a protocol for differentiating hiPSCs into pancreatic progenitor organoids and beta-like cells. The organoids obtained from this protocol contain beta, delta, and alpha cells.

STAR PROTOCOLS (2022)

Review Oncology

Tissue architecture in tumor initiation and progression

Jorge Almagro, Hendrik A. Messal, Alberto Elosegui-Artola, Jacco van Rheenen, Axel Behrens

Summary: The 3D architecture of tissues bearing tumors has significant impacts on the mechanical microenvironment of cancer, the accessibility of stromal cells, and the routes of invasion. Various forces from cancer cells, host tissue, and the molecular and cellular microenvironment modulate the morphology and malignant potential of the tumor through mechanical, biochemical, genetic, and epigenetic cues. Recent studies have revealed how tissue architecture influences cancer biology and progression.

TRENDS IN CANCER (2022)

Article Cell Biology

High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancer

Huafu Li, Chunming Wang, Linxiang Lan, Axel Behrens, Mona Tomaschko, Josue Ruiz, Qiao Su, Guangying Zhao, Cheng Yuan, Xing Xiao, Bo Li, Leping Yan, Wang Wu, Wuguo Li, Junzong Chen, Yulong He, Changhua Zhang

Summary: EMT plays a crucial role in the aggressiveness and metastasis of gastric cancer, especially in the infiltration of NK cells into tumor cells. Vinculin expression is closely related to cancer aggressiveness and distant metastasis, affecting patient survival prognosis. Additionally, VCL can influence EMT and tumor immunity by regulating EPCAM gene expression.

AGING-US (2021)

Review Oncology

Targeting the DNA Repair Enzyme Polymerase theta in Cancer Therapy

Anna Schrempf, Jana Slyskova, Joanna Loizou

Summary: Targeted cancer therapies focusing on POLQ, an error-prone translesion polymerase involved in DNA repair, represent a promising approach in personalized cancer treatment. Inhibition of POLQ, currently under development, shows potential for more effective cancer therapies in the future.

TRENDS IN CANCER (2021)

暂无数据